FDA NDC Directory · JSON-LD · Markdown

Dabigatran Etexilate

NDC 46708-635 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAlembic Pharmaceuticals Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA215233
Dosage form / routeCAPSULE · ORAL
Active ingredientsDABIGATRAN ETEXILATE MESYLATE (110 mg/1)
Marketing started20240813
Package count2

External sources

Source: openFDA. Public-domain (CC0).